dietaryr eference intakes in theu niteds tates...drugs(≠nutrients(≠bioac7ves(parameter drugs(...
TRANSCRIPT
DIETARY REFERENCE INTAKES IN THE UNITED STATES Taylor C. Wallace, PhD, CFS, FACN
October 27th, 2014
Disclosures
• Employment – George Mason University, Department of Food and NutriKon Studies
– Dr. Taylor Wallace – Food & NutriKon Blog – NaKonal Osteoporosis FoundaKon – NaKonal Bone Health Alliance
• Familiarize yourself with bioacKves. 1
• Understand the DRI process. 2
• Discuss why DRIs are needed for bioacKves? 3
Today’s Overview
• Explore the current DRIs for dietary fiber. 4
Nutrient
• Substance that provides structural or funcKonal components or energy to the body.
• Examples: vitamins, minerals, protein, carbs, fat, water and etc.
• EssenKal nutrients vs. non-‐essenKal nutrients
Essen7al Nutrient
• Substances that must be obtained from the diet because the body cannot make it in sufficient quanKty to meet its needs.
• Absence results in a deficiency disease (e.g. vitamin C and scurvy).
Bioac7ves
• Compounds that are consKtuents in foods and dietary supplements, other than those needed to meet basic human nutriKonal needs, which are responsible for changes in health status. NIH, Federal Resister, Vol 69, No. 179: Sept. 16, 2004, pp 55821-‐2.
• Examples: – Avenanthramides in oats – Anthocyanins in blueberries – Lutein in spinach
Bioac7ves
• Are typically absorbed from the diet.
• May be considered part of healthy diet (e.g. a diet rich in colorful fruits and vegetables).
• Absence does not result in a deficiency disease.
Bioac7ves
• Widely distributed in nature and the diet.
• Generally thought to be safe at normal nutriKonal consumpKon levels.
• Content in food is extremely variable based on environmental condiKons (e.g. temperature, alKtude, soil acidity and etc.).
• Some more well characterized than others…
Drugs ≠ Nutrients ≠ Bioac7ves
Parameter Drugs Nutrients Bioac7ves
Chemically defined and well characterized
Yes, single enKKes
Yes, single enKKes
No, complex mixtures
EssenKality None EssenKal Unclear
Inadequacy results in disease
No Yes No
True placebo group Yes No No
Targets Single organ or Kssue
All cells and Kssues
MulKple cells and Kssues
SystemaKc FuncKon Isolated Complex networks
Complex networks
Adapted from: Heber D and Shao A (2011)
Drugs ≠ Nutrients ≠ Bioac7ves
Parameter Drugs Nutrients Bioac7ves
Baseline status affects response to intervenKon
No Yes
Unclear
Effect size Large Small Small to moderate
Side effects Large Small Small
Nature of effect TherapeuKc PrevenKve PrevenKve and therapeuKc
Adapted from: Heber D and Shao A (2011)
Bioac7ves = Unique Characteris7cs
• Their structure, funcKon(s), biological acKvity may be defined as a class of compounds (e.g. avenanthramides in oats).
• Classes are typically found in similar types of foods (e.g. anthocyanins in raspberries and blackberries)
• OpKmal effects may be achieved through consumpKon of mixtures where the exact idenKty and composiKon is oeen unknown.
Dietary Reference Intakes
• Reference values that are quanKtaKve esKmates of nutrient intakes to be used for planning and assessing diets for healthy people. They include both recommended intakes and upper limits as reference values.
• DRI values: – EsKmated Average Requirement (EAR) – Recommended Dietary Allowance (RDA) – Adequate Intake (AI) – Tolerable Upper Intake Level (UL)
Why DRIs are Important!
Standards Science Review Programs Policy
Es7mated Average Requirement (EAR)
• The average daily nutrient intake level that is esKmated to meet the requirements of half of the healthy individuals in a parKcular life stage and gender group.
Recommended Dietary Allowance (RDA)
• The average daily dietary nutrient intake level that is sufficient to meet the nutrient requirements of nearly all (97.5%) healthy individuals in a parKcular life stage and gender group.
Adequate Intake (AI)
• The recommended average daily intake level based on observed or experimentally determined approximaKons or esKmates of nutrient intake by a group (or groups) of apparently healthy people that are assumed to be adequate.
• Used when an RDA cannot be determined.
Tolerable Upper Intake Level (UL)
• The highest average daily nutrient intake level that is likely to pose no risk of adverse health effects to almost all individuals in the general populaKon. As intake increases above the UL, the potenKal risk of adverse effects may increase.
• An “uncertainty factor” can be applied (e.g. vitamin D UL is 4,000 IU and NOAEL is 10,000 IU).
Dietary Reference Intakes
DRIs – Life Stage and Gender Groups
• Values are typically extrapolated for many age and gender groups (e.g. children).
Prevalence of Exceeding UL at 4-‐8 y.
0
10
20
30
40
Calcium Copper Iron Selenium Zinc
% >
UL
Food Only
Food + MVMM
Wallace TC, et al. (2012)
Framework for Developing DRIs • Availability of data and current research to inform the commilee deliberaKons. – Data is oeen limited (e.g. vitamin E). – Dose response data are key.
• IOM does not typically generate basic data.
• Framework is recognized as akin to a risk analysis, which analyzes and controls the “risks” that may be experienced by a populaKon of interest. In DRI development the risk is that nutrient intakes are too low or high.
Framework for Developing DRIs
• Although the reference values are based on data, the data are oeen scanty or drawn from studies that had limitaKons in addressing the quesKon.
• Ethical consideraKons…
Framework for Developing DRIs
• Funding and staff resources. – Approximately $250K to review a single nutrient. – IOM can only take <50% industry funds for a parKcular project.
• DRIs as loose-‐leaf notebooks.
Dietary Reference Intakes (DRIs)
• Tables of current DRIs can be found at: hlp://www.iom.edu/AcKviKes/NutriKon/SummaryDRIs/DRI-‐Tables.aspx.
• “Framework for DRI Development” (backgrounder paper) can be found at: hlp://www.iom.edu/AcKviKes/NutriKon/SummaryDRIs/~/media/Files/AcKvity%20Files/NutriKon/DRIs/New%20Material/11Bckgrd%20PaperFramework%20for%20DRI%20Devel.pdf
“Historically, the substances for which nutrient reference values have been developed were the essenKal or so-‐called classical nutrients, specifically vitamins, minerals, protein and energy (calories). As Kme has passed, substances found naturally in foods, ranging from fiber to carotenoids, have been incorporated into the DRI process.” -‐-‐ IOM, 2008
DRIs for Bioac7ves
• In 1998, phenols, polyphenols, and flavonoids were excluded from the DRI panel’s consideraKon due to lack of food composiKon data and knowledge of actual intake amounts and limited informaKon on their absorpKon and metabolism. – IOM Food and NutriPon Board (1998)
• Carotenoids were also reviewed in 2000 but were not assigned DRIs. – IOM Food and NutriPon Board (2000)
Why are DRIs Important for Bioac7ves? • BioacKves would be recognized as important for human health and evaluated accordingly. InvesKgators, regulatory agencies and consumers would all know how strong the science was behind messaging.
• Consumers and their HPCs would have a target to aim for in terms of intake.
• IncenKve for research to close criKcal gaps.
Why are DRIs Important for Bioac7ves?
• Having a DRI value increases the status of a bioacKve and makes it part of nutriKon public policy.
DRIs Provide Guidance for Claims
DRIs Provide Guidance for Claims
• 2010 Warning Leler to Unilever – Lipton Green Tea 100% Natural Naturally De-‐caffeinated
• The claim “packed with flavonoid anKoxidants” does not comply with 21 CFR 101.54(g)1) because no RDI has been established for flavonoids.
• Unauthorized nutrient content claim caused the product to be misbranded under secKon 403(r)(2)(A)(i) of the Act.
Establishing a Framework for Bioac7ves • ScienKfic frameworks on which to base intake recommendaKons for essenKal nutrients have been established. – Dietary Reference Intakes (DRIs) in US and Canada – Dietary Reference Values (DRVs) in Europe – Nutrient Reference Values (NRVs) published by CODEX Alimentarius
• No real solidified framework exists for bioacKves. So where do we start???
Dietary Fiber: A Case Study
• Non-‐essenKal
• Established an AI, but not EAR
• Based on intake levels observed to prevent CHD. Data included observaKonal, clinical, and mechanisKc.
• ReducKon of risk for diabetes used as secondary endpoint to support recommended intake levels .
Dietary Fiber: A Case Study
• Number of epidemiological studies showed individuals that consumed high amounts of dietary fiber and fiber-‐rich foods had reduced CHD risk.
• Large prospecKve cohort studies showed significant inverse relaKonship between total fiber intake and risk of CHD, together with evidence from clinical and mechanis7c data; an AI for total fiber was set.
Role of β-‐glucans
• Were shown to help normalize blood lipid levels and specifically decrease LDL-‐cholesterol (a validated biomarker of CHD) in hypercholesterolemic individuals.
• Dose response was shown among individuals with mulKple risk factors of CHD when oatmeal or oat bran (primary endpoint).
• Glucose responses were also reduced with β-‐glucan supplementaKon (secondary endpoint).
Lessons Learned from Fiber
• Reported benefits may be due to fiber source, not necessarily fiber per se (e.g. is it the fiber or the oats?).
• Overall dietary palern may be responsible for CHD effect.
• At lease some of the benefits associated with fiber may be due to other food components of fruits, vegetables, and cereal products (e.g. avenanthramides).
Concluding Thoughts
• Is a shie in focus from disease risk reducKon to markers of health and wellness feasible?
• Should focus be on maintaining normal physiological func7on throughout adulthood, which then leads to health promo7on?
• MulKple risk biomarkers may potenKally be helpful if all are showing the same beneficial effect on a parKcular health outcome (e.g., c-‐reacKve protein, various interleukins, etc.)
Concluding Thoughts
• DemonstraKng reduced risk of disease with a bioacKve is more difficult than it is to show prevenKon of a deficiency outcome with an essenKal nutrient. – Lupton JR et al. (2014)
• ScienKfic data needs to demonstrate consistent results. – needs to be valid, reliable & reproducible.
• We cannot solely depend on large RCTs to give us the answer.
THANK YOU! Taylor C. Wallace, PhD, CFS, FACN
www.drtaylorwallace.com